Weight Loss
Make your weight goals part of a clear care plan. Foundayo™ is an orforglipron tablet used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
From $305.35 /month
$305.35 for one month
Medication, shipping, clinician review and ongoing support included.
Renews automatically. Cancel anytime in the portal or email hello@consideritrx.com.
Continue to the secure intake form. An independent clinician reviews your history before any prescribing decision.
Your program, considered
Foundayo™ contains orforglipron and acts on appetite signals to help eligible patients reduce excess weight and maintain weight loss. It is used alongside reduced-calorie eating and increased physical activity.
This page concerns the named tablet medication and its labeled use. Prescribing, eligibility, supply and the complete program terms require confirmation.
See the research & risksClear pricing
Review the medication and strength choices. Your clinician confirms whether treatment fits before any prescription.
| Medication / strength | Route / form | One-month total |
|---|---|---|
| Foundayo™ Tablet — 0.8 mg | Tablet | $305.35One month · all included |
| Foundayo™ Tablet — 2.5 mg | Tablet | $352.90One month · all included |
| Foundayo™ Tablet — 5.5 mg | Tablet | $462.90One month · all included |
| Foundayo™ Tablet — 9 mg | Tablet | $462.90One month · all included |
| Foundayo™ Tablet — 14.5 mg | Tablet | $462.90One month · all included |
| Foundayo™ Tablet — 17.2 mg | Tablet | $462.90One month · all included |
Care that considers you
Share your health history, medicines and goals in the secure intake form.
A licensed clinician reviews the evidence, risks and alternatives with you.
If prescribed, confirm the exact formula, directions, full cost and follow-up.
The details that matter
Know the evidence.
Make an informed decision.
Orforglipron is an oral GLP-1 receptor agonist. It acts on signaling involved in appetite and blood-glucose regulation.
The prescribing information summarizes trials and safety findings for this named product. Eligibility and expected outcomes depend on the studied population, labeled use and individual health history.
Primary prescribing information · 2026
Review the named product’s clinical trials, eligible populations, contraindications and safety information. The oral-tablet section is the relevant source for this page.
Study results are not a promise of personal results. Research on one formula or route does not establish the same results for another.
This page concerns the named tablet medication and its labeled use. Prescribing, eligibility, supply and the complete program terms require confirmation.
Gastrointestinal effects such as nausea, vomiting, diarrhea or constipation may occur. Severe abdominal pain, dehydration or an allergic reaction requires prompt care. Your clinician reviews the complete product warning and interactions.
Orforglipron is the active ingredient in the named tablet. The manufacturer label also lists inactive ingredients.
No. This program concerns the named manufacturer product. CIRx provides the care program and clinician review.
This page covers the tablet presentation. Any other format has its own program page and prescribing information.
Follow the directions provided with your prescription. Your clinician and dispensing pharmacy confirm the dose, preparation, storage and follow-up. The product image is not a dosing guide.
You can start secure intake now. A licensed clinician reviews your health history, medicines and goals, then confirms whether treatment is appropriate.
This browsing page does not collect medical information. Share health details only in the secure care portal.
Your next chapter
Start with your goals. A licensed clinician helps you understand what fits.
TirzeMelt is an Epiq compounded sublingual tablet. Compare one-month plans and clinician-approved three-month maintenance at a fixed strength. Start, restart and dose changes require provider confirmation.
Medication, shipping, clinician review and ongoing support included.
Explore program
SemaMelt is an Epiq compounded sublingual tablet. Compare one-month plans and clinician-approved three-month maintenance at a fixed strength. Start, restart and dose changes require provider confirmation.
Medication, shipping, clinician review and ongoing support included.
Explore program
Make your weight goals part of a clear care plan. Zepbound® is a tirzepatide injection used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore program